Inteligencia Farmaceutica

What Inteligencia Farmaceutica does

Rune Inteligencia Farmacéutica SL (operating as Inteligencia Farmacéutica) is a privately held Spanish technology company founded in 2017 and headquartered in Sueca, Valencia. The company develops the Advana platform ecosystem, a set of B2B software solutions purpose-built for digitizing the biomedical and pharmaceutical supply chain. Its three core products are Advana Lab (a customized solutions ecosystem), Advana Intelligence (a Big Data platform that analyzes a customer's own data alongside competitor data in real time), and Advana Projects (R+D+i consulting, digitization project development, and public funding roadmap advisory). Underlying the platform are Big Data infrastructure, Artificial Intelligence algorithms, and Business Intelligence software, supplemented by proprietary Deep Learning models based on deep neural networks (the DeepPharma project, co-financed by IVACE and FEDER in 2019) for pharmaceutical demand forecasting targeting stock reduction, waste reduction and improved delivery times.

The company serves four customer segments across the pharmaceutical value chain — laboratories, wholesalers, pharmacies and hospitals — with publicly displayed customer logos including Stada, Teva, Ratiopharm, Pensa, Kern, Aurovitas and Apotex, all pharmaceutical laboratories. It operates a sales-led B2B go-to-market with direct enterprise outreach, remote work and on-premise client installations, and is currently in a self-described national and international expansion phase. Pricing is not publicly disclosed; product positioning (enterprise SaaS-style software solutions and platforms with R+D+i consulting) suggests subscription or recurring licensing revenue mechanics, but no ARR or revenue figure is publicly reported.

Inteligencia Farmacéutica is funded primarily through non-dilutive public instruments rather than equity capital. Cumulative disclosed grants include €65,056.88 from IVACE/FEDER (2019, DeepPharma), IVACE internationalization support (file ITATUT/2021/63), €28,728 from LABORA for youth hiring (2023), and a 2024 EU Talent Promotion L2 grant for the EVOLUCIÓN DE ADVANA project. The company holds a PYME Innovadora certification, is a Microsoft for Startups member, and operates a bilingual Spanish/English website. Headcount sits in the 11–50 range with active 2024 hiring for a Tech Lead and two Full-Stack Developers in Product Development.

Name

Inteligencia Farmaceutica

Legal name

Rune Inteligencia Farmacéutica SL

Website

https://inteligenciafarmaceutica.com

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

11–50 employees

Short description

Valencia-based B2B technology company (Rune Inteligencia Farmacéutica SL) that provides the Advana platform ecosystem for digitizing the pharmaceutical and biomedical supply chain, serving laboratories, wholesalers, pharmacies and hospitals with Big Data, AI, and Deep Learning-based demand forecasting tools.

Ownership category

akta.pro rank

Product category

Pharmaceutical Supply Chain Analytics

NAICS

Software Publishers (513210), Custom Computer Programming Services (541511)

SIC

Services-Prepackaged Software (7372), Services-Computer Programming, Data Processing, Etc. (7370)

akta.pro primary industry

iBPMS (Intelligent BPM Suites) & Process Automation Suites (HDAEAHAG)

akta.pro secondary industry

Model Development & Training Platforms (AutoML, Notebooks, Feature Stores) (HDAEANAB)

Keywords

• Pharmaceutical supply chain
• Biomedical data analytics
• Demand forecasting software
• Big data platforms
• Business intelligence tools

Headquarters

HQ city

Valencia

HQ country

Spain

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Software Solutions (Advana Platform): B2B SaaS-style software solutions and platforms for digitizing the biomedical supply chain, including Big Data analytics, AI-powered intelligence, and R+D+i consulting services. Revenue likely derives from subscription/recurring licensing model based on the enterprise software positioning.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Inteligencia Farmacéutica develops and sells the Advana software ecosystem, a Big Data and AI-powered platform that digitizes the biomedical and pharmaceutical supply chain. The offering combines real-time data integration, competitive intelligence, and deep learning-based demand forecasting to connect laboratories, wholesalers, pharmacies, and hospitals end-to-end. Complementary R+D+i consulting and digitization project services are delivered under the same Advana brand.

Product overview

Inteligencia Farmacéutica offers a unified platform ecosystem called Advana, designed for digitizing the biomedical and pharmaceutical supply chain. The platform consists of three integrated modules: Advana Intelligence (Big Data platform for real-time analysis of own and competitor data), Advana Lab (customized ecosystem solutions tailored to customer needs), and Advana Projects (R+D+i consulting, digitization project development, and funding roadmap services). All Advana solutions are built on Big Data infrastructure, Artificial Intelligence algorithms, and Business Intelligence software, providing end-to-end integration, visibility, and real-time data availability across the pharmaceutical value chain.

Differentiator

Problem solved

Functional benefit

Brands

• Advana: Ecosystem of customized solutions for digital transformation of biomedical supply chain, including Advana Lab (customized solutions), Advana Intelligence (Big Data platform for real-time data analysis), and Advana Projects (R&D+i consulting and digitization project development).

Products and services

• Advana Platform (Advana Lab) Customized ecosystem of digital solutions tailored to pharmaceutical and biomedical supply chain operators, providing adaptable tools that improve customer experience and integrate the various agents of the value chain.
• Advana Intelligence Big Data platform that performs real-time analysis of the customer's own data and competitor data to boost market position in the pharmaceutical sector, built on Big Data infrastructure, Artificial Intelligence algorithms, and Business Intelligence software.
• Advana Projects R+D+i consulting service that develops digitization projects for clients and builds roadmaps to access R+D+i grant funding, targeted at pharmaceutical and biomedical sector organizations.

Quantifiable outcome

• Stock reduction through demand forecasting (DeepPharma project)
• +3 more outcomes

Named customers7 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature8 records

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• IQVIA: Global leader in healthcare data, analytics, and technology for life sciences and pharma supply chains. Comparable as a large incumbent offering Big Data and AI-driven pharma commercial/supply-chain intelligence — overlapping with Advana Intelligence at much greater scale.
• Veeva Systems: Cloud software provider serving the global life-sciences industry with CRM, data, and commercial operations platforms. Comparable as a vertical SaaS incumbent in pharma with deep customer penetration among the same labs shown in IF's customer logos.
• SAP (Pharma/Healthcare SCM): Enterprise software incumbent whose supply-chain and analytics modules are widely deployed in pharmaceutical manufacturing and distribution. Overlaps with Advana on real-time supply-chain visibility and BI, though as part of a much broader portfolio.
• Salesforce (Health Cloud / Pharma): Horizontal CRM/cloud platform with healthcare and life-sciences vertical offerings for pharma commercial operations. Comparable as a broad incumbent competing for the same pharma customer wallet for CRM, partner management, and real-time data.
• Oracle Health Sciences: Oracle's life-sciences and pharma commercial/supply-chain suite, offering data and analytics for manufacturers. Comparable as a broad incumbent tackling pharma data integration and analytics that IF targets at the mid-market and specialty-generics level.

Emerging players

• TrinetX: Health-data analytics platform serving life-sciences organizations with real-world data and analytics. Adjacent comparator on the pharma-data/AI side, though focused more on clinical and real-world evidence than supply-chain forecasting.
• OptimizeRx: Digital health company providing AI-driven analytics and messaging to pharma manufacturers, focused on commercial and adherence outcomes. Comparable as an emerging vertical SaaS vendor leveraging AI for pharma decision support.
• GlobalData (Pharma): Data analytics provider offering competitive intelligence, market sizing, and pharma supply-chain datasets. Comparable on the analytics and competitive-intelligence layer of Advana Intelligence, particularly the competitor-data benchmarking IF highlights.

Direct peers

• Cegedim: French-headquartered software and data services company specialized in the pharmaceutical value chain (CRM, sales-data, supply-chain visibility for labs, wholesalers, and pharmacies). Closest like-for-like peer in terms of vertical pharma supply-chain SaaS in Europe.
• Inmar (Pharma Supply Chain): Provides pharmaceutical supply-chain, returns, and data-analytics solutions to manufacturers and wholesalers. Comparable as a specialist vendor in pharma supply-chain optimization and data-driven decisioning, similar to IF's DeepPharma/Advana value proposition.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Inteligencia Farmaceutica